LATE STAGE ONCOLOGY MCDA CRITERIA IMPLEMENTATION RESULTS IN EUROPEAN COUNTRIES
Author(s)
Bertalan Nemeth, MSc, Syreon Research Institute, Budapest, Hungary; Oresta Piniazhko, PhD, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine; Aleksandra Zawodnik, MSc Pharm, Medical University of Warsaw, Warsaw, Poland
Presentation Documents
Late stage oncology Multi-Criteria Decision Analysis (MCDA) inter- dependence of the following criteria will be explored: efficacy, budget impact, safety, unmet needs, strategic & patient preference. Introduction to each criteria will be provided to the audience. Scoring comparison between different countries will be performed. Presenters will demonstrate late stage oncology MCDA criteria transferability and application across European countries. Audience engagement is anticipated during the meeting.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Code
F9
Topic
Health Technology Assessment, Organizational Practices